Clinical Trial: The Effect of Magnesium Oxide on Plasma Phosphate in Hemodialysis Patients

Study Status: Completed
Recruit Status: Completed
Study Type: Observational [Patient Registry]

Official Title:

Brief Summary: Hyperphosphatemia is a common problem in hemodialysis (HD) patients. Different chelators for control of Hyperphosphatemia are used. The aim of this study was to assess the effect of magnesium oxide (Mg Oxide) on the control of serum phosphorus (P) level and evaluation of its side effects in hemodialysis patients.

Detailed Summary:
Sponsor: Shiraz University of Medical Sciences

Current Primary Outcome: plasma phosphate level [ Time Frame: 4 week ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Shiraz University of Medical Sciences

Dates:
Date Received: May 4, 2013
Date Started: June 2012
Date Completion:
Last Updated: May 12, 2013
Last Verified: May 2013